Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France

[1]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[2]  P. Colson,et al.  Polymorphism and drug‐selected mutations in the reverse transcriptase gene of HIV‐2 from patients living in southeastern France , 2005, Journal of medical virology.

[3]  P. Colson,et al.  Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Dabis,et al.  HBV and HCV prevalence and viraemia in HIV‐positive and HIV‐negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 study , 2004, Journal of medical virology.

[5]  F. Fack,et al.  Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. , 2004, The Journal of infectious diseases.

[6]  O. Erhabor,et al.  The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. , 2004, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.

[7]  R. Salamon,et al.  Factors associated with clinical progression in HIV-2 infected-patients: The French ANRS cohort , 2003, AIDS.

[8]  R. Doms,et al.  Human immunodeficiency virus type 2. , 2002, The Journal of general virology.

[9]  H. Sakai,et al.  Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[10]  C. Hunt,et al.  Clinical relevance of hepatitis B viral mutations , 2000, Hepatology.

[11]  J. Delfraissy,et al.  Prise en charge thérapeutique des personnes infectées par le VIH , 2000 .

[12]  T. Berg,et al.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.